Ricer (Rituximab, Ifosfamide, Carboplatin, Etoposide, Revlimid) Is Well-Tolerated Salvage Regimen in First Relapse/Primary Refractory DLBCL Allowing Consolidation with Autologous Stem Cell Transplant
- Resource Type
- Journal
- Authors
- Feldman, Tatyana; Mato, Anthony R.; Donato, Michele L.; Rowley, Scott D.; Goldberg, Stuart L.; Carini, Carolanne; Valentinetti, Marisa; Smith, Judith; Gadaleta, Gabriella; Bejot, Coleen; Stives, Susan; Timberg, Mary; Protomastro, Ewelina A.; Richter, Joshua R.; Vesole, David H.; Pecora, Andrew L.; Siegel, David S.; Goy, Andre
- Source
- BLOOD; NOV 16 2012, 120 21, 3p.
- Subject
- Language
- English
- ISSN
- 00064971